Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2022-09-21 00:00:00 ET · period of report 2022-09-20 · accession 0001140361-22-034312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-21 | 2022-09-20 | ERNA | Sidhu Roger | Chief Medical Off | M - OptEx | — | +20.2K | 20.2K | New | — |
| D | 2022-09-21 | 2022-09-20 | ERNA | Sidhu Roger | Chief Medical Off | M - OptEx | $0.00 | -20.2K | 60.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-20 | M | A | 20,163 | — | 20,163 | D | — | — | (F1) Each restricted stock unit converts into one share of common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-09-20 | M | D | 20,163 | $0.00 | 60,487 | D | — · — to — | 20,163 Common Stock | (F1) Each restricted stock unit converts into one share of common stock. (F2) On September, 2021, the reporting person was granted 80,650 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date. |